Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Login
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press/Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
Philips CX50 CompactXtreme ultrasound system
Schlaich, Markus
(Investigator 01)
Watts, Gerald
(Investigator 02)
Croft, Kevin
(Investigator 03)
Hodgson, Jonathan
(Investigator 04)
Beilin, Lawrence
(Investigator 05)
Mori, Trevor
(Investigator 06)
Internal Medicine
Pharmacology and Toxicology
Overview
Research output
(1)
Project Details
Status
Finished
Effective start/end date
1/01/16
→
31/12/17
Funding
NHMRC National Health and Medical Research Council :
A$50,000.00
View all
View less
Research output
Research output per year
2021
2021
2021
1
Article
Research output per year
Research output per year
Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first-line antihypertensive therapy
Carnagarin, R.
, Nolde, J. M.,
Ward, N. C.
, Lugo-Gavidia, L. M.,
Chan, J.
,
Robinson, S.
,
Jose, A.
, Joyson, A., Azzam, O., Galindo Kiuchi, M.,
Mwipatayi, B. P.
&
Schlaich, M. P.
,
Jul 2021
,
In:
Journal of Clinical Hypertension.
23
,
7
,
p. 1380-1389
10 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Hypertension
100%
Homocysteine
100%
Antihypertensive Agent
100%
Antihypertensive Therapy
100%
Aldosterone
30%
11
Citations (Scopus)